<DOC>
	<DOC>NCT01457001</DOC>
	<brief_summary>Multicentric randomized Italian clinical trial, open label, not for profit. To evaluate the efficacy of 25-OH-D vitamin in terms of myocardial infarction, stroke, sudden death, death for other causes in chronic haemodialysis patients. Two arms of treatment: 25-OH-D vitamin per os versus no treatment.</brief_summary>
	<brief_title>Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<criteria>age &gt;= 18 years hematic PTH level twofoldninefold the upper limit hematic level of 25OHD vitamin &lt; 30 ng/ml renal transplant or peritoneal dialysis less than 3 years ago pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>chronic haemodialysis</keyword>
	<keyword>25-OH-D vitamin</keyword>
</DOC>